What NAD+ is
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell. It's required for hundreds of enzymatic reactions including energy production (mitochondrial function), DNA repair (via PARP enzymes), and cellular signaling (via sirtuins). When NAD+ levels are adequate, cells produce energy efficiently, repair damage, and respond to stress. When NAD+ is low, all of these functions diminish.
Why NAD+ declines
NAD+ levels drop roughly 50% from age 20 to age 60. Reasons:
- Increased consumption by chronic inflammation, DNA damage, and metabolic stress
- Reduced biosynthesis from precursors
- Increased CD38 enzyme activity (degrades NAD+) with age
- Lifestyle factors: poor sleep, alcohol, sedentary behavior, obesity
The decline is consistent enough that NAD+ levels are sometimes cited as a biomarker of cellular aging.
The current evidence
What's well-established:
- NAD+ levels can be raised with oral NMN or NR, multiple human trials confirm this
- Animal models show consistent benefits: improved metabolic health, mitochondrial function, lifespan in some species
What's less clear in humans:
- Whether higher NAD+ translates to measurable clinical outcomes
- Whether subjective benefits (energy, mental clarity) are placebo-resistant
- Long-term safety at common doses (no major signals; data is still maturing)
- Optimal dose, route, and frequency
The honest take: precursors clearly raise NAD+ levels. The "so what" question, does this prevent disease or extend healthspan in humans?, is plausible but not yet conclusively answered.
Delivery routes
| Route | Notes |
|---|---|
| Oral NMN (nicotinamide mononucleotide) | Reliable NAD+ elevation; convenient; lower cost |
| Oral NR (nicotinamide riboside) | Similar to NMN; both well-evidenced for blood NAD+ rise |
| Subcutaneous NAD+ | Direct delivery; subjectively reported strong effects |
| IV NAD+ infusion | Highest acute exposure; intense subjective experience |
NMN vs NR
Both raise NAD+. Recent FDA action removed NMN from "dietary supplement" status (it's now treated as an investigational drug), making NR more available in over-the-counter markets. Both work; NR has the more established commercial supply chain at the moment.
IV NAD+
IV NAD+ infusions deliver large doses in a 2-4 hour session. Many patients report dramatic short-term effects, increased mental clarity, energy, and well-being. The subjective effect is real for many people. Whether the long-term benefit justifies the cost (typically considerable) and time investment depends on personal goals.
Who actually benefits
- Adults 40+ with declining energy and mitochondrial complaints
- Patients post-illness recovery
- Adults committed to comprehensive longevity protocols
- Patients addressing chronic fatigue with otherwise unexplained labs
Not appropriate as a substitute for: addressing actual hormone deficiencies, sleep, training, nutrition, or other foundation work that has stronger evidence.
The principle: NAD+ is plausible, popular, and partially evidenced. It's a refined adjunct, not a foundation. For someone with the foundations dialed in and resources to invest in plausible-but-emerging tools, it has a place. For someone deciding whether to spend on NAD+ or fix their sleep, fix sleep first.
Bottom line
NAD+ is a real biological factor. Boosting it is achievable. Whether the boost translates to meaningful clinical outcomes is plausible but not yet definitive. For health-optimizers committed to the foundation work, NAD+ is a reasonable next-tier addition, particularly via convenient oral precursors. For anyone choosing one priority, the basics (sleep, training, hormones, metabolic health) deliver more measurable benefit per dollar.